Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Fatal Hemoptysis Due to Endobronchial Aspergilloma in the Hyperinflated Native Lung after Single-Lung Transplantation for Lymphangioleiomyomatosis: A Case Report.

Yoshizaki A, Yamamoto M, Hirabayashi A, Ono Y, Hatakeyama Y, Nakata K, Tamura D, Tachihara M, Kamiryo H, Kobayashi K, Nishio M, Nishimura Y.

Kobe J Med Sci. 2020 Jan 20;65(4):E114-E117.

2.

Acute exacerbation of interstitial lung disease with onset of myositis in systemic sclerosis patients: a report of two cases.

Nakamura K, Ichimura Y, Tamaki Z, Yoshizaki A, Sato S, Asano Y.

Scand J Rheumatol. 2020 Feb 27:1-2. doi: 10.1080/03009742.2019.1690041. [Epub ahead of print] No abstract available.

PMID:
32102590
3.

Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.

Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Sato S.

J Dermatol. 2020 Feb 24. doi: 10.1111/1346-8138.15274. [Epub ahead of print]

PMID:
32096271
4.

Survey of Japanese dermatological vasculitis specialists on cases of cutaneous arteritis (cutaneous polyarteritis nodosa).

Ikeda T, Kawakami T, Arimura Y, Ishiguro N, Ishizu A, Ito F, Ito-Ihara T, Okiyama N, Ono S, Suzuki K, Sugawara K, Seishima M, Kodera M, Tanaka M, Hasegawa M, Furukawa F, Yamaguchi Y, Yoshizaki A; Revised Committee for guidelines for the management of vasculitis, vascular disorders of the Japanese Dermatological Association.

J Dermatol. 2020 Feb 24. doi: 10.1111/1346-8138.15273. [Epub ahead of print]

PMID:
32096266
5.

Serum delta-like 4 levels: A possible association with interstitial lung disease in systemic sclerosis.

Fukui Y, Miyagawa T, Toyama S, Omatsu J, Hirabayashi M, Nakamura K, Yoshizaki A, Sato S, Asano Y.

J Dermatol. 2020 Jan 26. doi: 10.1111/1346-8138.15245. [Epub ahead of print] No abstract available.

PMID:
31984546
6.

Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma.

Miura S, Asano Y, Saigusa R, Yamashita T, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Sato S, Kadono T.

J Dermatol Sci. 2020 Feb;97(2):125-134. doi: 10.1016/j.jdermsci.2020.01.002. Epub 2020 Jan 15.

PMID:
31959382
7.

Classification Algorithm for Nocturnal Hypoxemia Using Nocturnal Pulse Oximetry.

Izumi S, Nagano T, Yoshizaki A, Nishimura Y.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:3662-3665. doi: 10.1109/EMBC.2019.8856384.

PMID:
31946671
8.

Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.

Miyagawa T, Taniguchi T, Saigusa R, Fukayama M, Takahashi T, Yamashita T, Hirabayashi M, Miura S, Nakamura K, Yoshizaki A, Sato S, Asano Y.

Rheumatology (Oxford). 2019 Nov 29. pii: kez517. doi: 10.1093/rheumatology/kez517. [Epub ahead of print]

PMID:
31782787
9.

Cytokine analysis on a countable number of molecules from living single cells on nanofluidic devices.

Nakao T, Kazoe Y, Mori E, Morikawa K, Fukasawa T, Yoshizaki A, Kitamori T.

Analyst. 2019 Dec 2;144(24):7200-7208. doi: 10.1039/c9an01702j.

PMID:
31691693
10.

Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation.

Enomoto A, Fukasawa T, Tsumoto H, Karube M, Nakagawa K, Yoshizaki A, Sato S, Miura Y, Miyagawa K.

Sci Rep. 2019 Nov 5;9(1):16010. doi: 10.1038/s41598-019-52435-8.

11.

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.

Ebata S, Yoshizaki A, Fukasawa T, Miura S, Takahashi T, Sumida H, Asano Y, Sato S.

J Dermatol. 2019 Nov;46(11):1006-1013. doi: 10.1111/1346-8138.15079. Epub 2019 Sep 9.

PMID:
31502326
12.

Cutaneous phaeohyphomycosis caused by Alternaria alternata in an immunosuppressed patient.

Suda K, Yamashita T, Kawase Y, Yarita K, Yoshizaki A, Akamata K, Asano Y, Kamei K, Sato S.

J Dermatol. 2019 Dec;46(12):e448-e449. doi: 10.1111/1346-8138.15041. Epub 2019 Aug 20. No abstract available.

PMID:
31432527
13.

Photobiomodulation therapy combined with carvedilol attenuates post-infarction heart failure by suppressing excessive inflammation and oxidative stress in rats.

Grandinetti V, Carlos FP, Antonio EL, de Oliveira HA, Dos Santos LFN, Yoshizaki A, Mansano BSDM, Silva FA, Porte LA, Albuquerque-Pontes GM, de Carvalho PTC, Manchini MT, Leal-Junior EC, Tucci PJF, Serra AJ.

Sci Rep. 2019 Jul 1;9(1):9425. doi: 10.1038/s41598-019-46021-1.

14.

Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.

Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Miura S, Toyama T, Yoshizaki A, Sumida H, Asano Y, Oba K, Sato S.

Arthritis Res Ther. 2019 May 28;21(1):129. doi: 10.1186/s13075-019-1919-6.

15.

Possible association of decreased serum CXCL14 levels with digital ulcers in patients with systemic sclerosis.

Fukui Y, Miyagawa T, Hirabayashi M, Yamashita T, Saigusa R, Miura S, Nakamura K, Yoshizaki A, Sato S, Asano Y.

J Dermatol. 2019 Jul;46(7):584-589. doi: 10.1111/1346-8138.14914. Epub 2019 May 14.

PMID:
31087594
16.

Serum levels of human β-defensin 2: possible association with fibrosis and vasculopathy in patients with systemic sclerosis.

Kuzumi A, Yoshizaki A, Fukasawa T, Ebata S, Miura S, Yoshizaki A, Sumida H, Asano Y, Sato S.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):e272-e274. doi: 10.1111/jdv.15546. Epub 2019 Mar 28. No abstract available.

PMID:
30835873
17.

A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis.

Saigusa R, Yamashita T, Miura S, Hirabayashi M, Nakamura K, Miyagawa T, Fukui Y, Yoshizaki A, Sato S, Asano Y.

Exp Dermatol. 2019 May;28(5):536-542. doi: 10.1111/exd.13900.

PMID:
30739341
18.

Non-parallel anti-tumour effects of pembrolizumab: a case of cardial tamponade.

Tachihara M, Yamamoto M, Yumura M, Yoshizaki A, Kobayashi K, Nishimura Y.

Respirol Case Rep. 2019 Jan 31;7(3):e00404. doi: 10.1002/rcr2.404. eCollection 2019 Apr.

19.

Problems, goals and solutions reported by cancer patients participating in group problem-solving therapy.

Matsui T, Hirai K, Shokoji M, Kanai N, Yoshizaki A, Wada N, Ito N, Tokuyama M.

Jpn J Clin Oncol. 2019 Mar 1;49(3):245-256. doi: 10.1093/jjco/hyy191.

PMID:
30715425
20.

Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.

Kamata M, Asano Y, Shida R, Maeda N, Yoshizaki A, Miyagaki T, Kawashima T, Tada Y, Sato S.

J Dermatol. 2019 Jun;46(6):e216-e217. doi: 10.1111/1346-8138.14760. Epub 2019 Jan 10. No abstract available.

PMID:
30628103
21.

Leprosy with spontaneous type 1 lepra reaction as an initial cutaneous manifestation: a case from Japan.

Noda M, Tsunemi Y, Masui Y, Yoshizaki A, Ohmatsu H, Takazawa Y, Ishii N.

Eur J Dermatol. 2018 Dec 1;28(6):843-844. doi: 10.1684/ejd.2018.3428. No abstract available.

PMID:
30563805
22.

Case of purpuric drug eruption probably induced by panitumumab.

Senda N, Miyagaki T, Oka T, Nonogaki A, Yoshizaki A, Shibata S, Sato S.

J Dermatol. 2019 Jun;46(6):e221-e222. doi: 10.1111/1346-8138.14724. Epub 2018 Dec 7. No abstract available.

PMID:
30537161
23.

A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.

Miyagawa T, Asano Y, Saigusa R, Hirabayashi M, Yamashita T, Taniguchi T, Takahashi T, Nakamura K, Miura S, Yoshizaki A, Miyagaki T, Sato S.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):753-760. doi: 10.1111/jdv.15387. Epub 2019 Jan 1.

PMID:
30520152
24.

Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy.

Yamashita T, Asano Y, Saigusa R, Taniguchi T, Hirabayashi M, Miyagawa T, Nakamura K, Miura S, Yoshizaki A, Trojanowska M, Sato S.

J Invest Dermatol. 2019 May;139(5):1150-1160. doi: 10.1016/j.jid.2018.11.016. Epub 2018 Nov 30.

PMID:
30508546
25.

Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.

Senda N, Miyagaki T, Kamijo H, Nakajima R, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

Eur J Dermatol. 2018 Oct 1;28(5):621-627. doi: 10.1684/ejd.2018.3400.

PMID:
30378541
26.

Starvation-induced Liver Enzyme Elevation after Initiation of Feeding.

Nishioka H, Yoshizaki A, Imai Y, Higashibeppu N.

Intern Med. 2019 Mar 1;58(5):749-753. doi: 10.2169/internalmedicine.1663-18. Epub 2018 Oct 17.

27.

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study.

Sumida H, Asano Y, Tamaki Z, Aozasa N, Taniguchi T, Toyama T, Takahashi T, Ichimura Y, Noda S, Akamata K, Saigusa R, Miyazaki M, Kuwano Y, Yanaba K, Yoshizaki A, Sato S.

J Dermatol. 2018 Dec;45(12):1425-1433. doi: 10.1111/1346-8138.14669. Epub 2018 Oct 5.

PMID:
30289572
28.

Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.

Yamashita T, Asano Y, Saigusa R, Taniguchi T, Nakamura K, Miura S, Toyama T, Takahashi T, Ichimura Y, Hirabayashi M, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol Sci. 2019 Jan;93(1):24-32. doi: 10.1016/j.jdermsci.2018.09.007. Epub 2018 Sep 21.

PMID:
30270117
29.

Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.

Miyagawa T, Ichimura Y, Nakamura K, Hirabayashi M, Yamashita T, Saigusa R, Miura S, Takahashi T, Toyama T, Taniguchi T, Akamata K, Yoshizaki A, Sato S, Asano Y.

J Dermatol Sci. 2018 Nov;92(2):207-214. doi: 10.1016/j.jdermsci.2018.09.005. Epub 2018 Sep 19.

PMID:
30268392
30.

Atrial fibrillation promotion in a rat model of heart failure induced by left ventricle radiofrequency ablation.

Dos Santos L, Antonio EL, Serra AJ, Yoshizaki A, Seibt L, Silva FA, Couto GK, Rossoni LV, Tucci P, de Paola AA, Fenelon G.

Int J Cardiol Heart Vasc. 2018 Sep 22;21:22-28. doi: 10.1016/j.ijcha.2018.09.003. eCollection 2018 Dec.

31.

IL-10-Producing Regulatory B Cells Are Decreased in Patients with Atopic Dermatitis.

Yoshihara Y, Ishiuji Y, Yoshizaki A, Kurita M, Hayashi M, Ishiji T, Nakagawa H, Asahina A, Yanaba K.

J Invest Dermatol. 2019 Feb;139(2):475-478. doi: 10.1016/j.jid.2018.08.016. Epub 2018 Sep 17. No abstract available.

32.

Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells.

Kawa Y, Nagano T, Yoshizaki A, Dokuni R, Katsurada M, Terashita T, Yasuda Y, Umezawa K, Yamamoto M, Kamiryo H, Kobayashi K, Nishimura Y.

PLoS One. 2018 Sep 7;13(9):e0203211. doi: 10.1371/journal.pone.0203211. eCollection 2018.

33.

Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survival.

Nakao M, Nakamura K, Fukasawa T, Shida R, Ito A, Ichimura Y, Takahashi T, Mitsui A, Yoshizaki A, Shibata S, Kamata M, Araki M, Watanabe R, Sato S, Asano Y.

Int J Dermatol. 2019 Jan;58(1):54-59. doi: 10.1111/ijd.14200. Epub 2018 Aug 31.

PMID:
30168849
34.

Successful treatment of palmoplantar pustular psoriasis with brodalumab.

Nakao M, Asano Y, Kamata M, Yoshizaki A, Sato S.

Eur J Dermatol. 2018 Aug 1;28(4):538-539. doi: 10.1684/ejd.2018.3325. No abstract available.

PMID:
30129522
35.

An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis.

Yamashita T, Lakota K, Taniguchi T, Yoshizaki A, Sato S, Hong W, Zhou X, Sodin-Semrl S, Fang F, Asano Y, Varga J.

Sci Rep. 2018 Aug 7;8(1):11843. doi: 10.1038/s41598-018-29901-w.

36.

Rapid alteration of serum interleukin-6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis-associated interstitial lung disease.

Numajiri H, Yoshizaki A, Fukasawa T, Ebata S, Nakamura K, Yamashita T, Saigusa R, Miura S, Hirabayashi M, Yoshizaki A, Sumida H, Asano Y, Kazoe Y, Mawatari K, Kitamori T, Sato S.

J Dermatol. 2018 Oct;45(10):1221-1224. doi: 10.1111/1346-8138.14580. Epub 2018 Jul 27.

PMID:
30051925
37.

Serum interleukin-34 levels in patients with systemic sclerosis: Clinical association with interstitial lung disease.

Kuzumi A, Yoshizaki A, Toyama S, Fukasawa T, Ebata S, Nakamura K, Yamashita T, Saigusa R, Miura S, Hirabayashi M, Yoshizaki A, Asano Y, Sato S.

J Dermatol. 2018 Oct;45(10):1216-1220. doi: 10.1111/1346-8138.14538. Epub 2018 Jul 13.

PMID:
30004593
38.

Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.

Akatsuka T, Miyagaki T, Nakajima R, Kamijo H, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

Eur J Dermatol. 2018 Jun 1;28(3):314-319. doi: 10.1684/ejd.2018.3319.

PMID:
29952298
39.

CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.

Taniguchi T, Miyagawa T, Toyama S, Yamashita T, Nakamura K, Saigusa R, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Sato S, Asano Y.

Exp Dermatol. 2018 Sep;27(9):1030-1037. doi: 10.1111/exd.13724. Epub 2018 Jul 29.

PMID:
29947047
40.

Exacerbated Immune Complex-Mediated Vascular Injury in Mice with Heterozygous Deficiency of Aryl Hydrocarbon Receptor through Upregulation of Fcγ Receptor III Expression on Macrophages.

Nakajima R, Miyagaki T, Morimura S, Fukasawa T, Oka T, Yoshizaki A, Sugaya M, Sato S.

J Invest Dermatol. 2018 Oct;138(10):2195-2204. doi: 10.1016/j.jid.2018.03.1520. Epub 2018 Mar 30.

41.

Protective effects of photobiomodulation against resistance exercise-induced muscle damage and inflammation in rats.

de Oliveira HA, Antonio EL, Silva FA, de Carvalho PTC, Feliciano R, Yoshizaki A, Vieira SS, de Melo BL, Leal-Junior ECP, Labat R, Bocalini DS, Silva Junior JA, Tucci PJF, Serra AJ.

J Sports Sci. 2018 Oct;36(20):2349-2357. doi: 10.1080/02640414.2018.1457419. Epub 2018 Mar 26.

PMID:
29578836
42.

Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.

Saigusa R, Asano Y, Taniguchi T, Hirabayashi M, Nakamura K, Miura S, Yamashita T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Trojanowska M, Sato S.

Arthritis Res Ther. 2018 Feb 7;20(1):23. doi: 10.1186/s13075-018-1521-3.

43.

Pathogenic roles of B lymphocytes in systemic sclerosis.

Yoshizaki A.

Immunol Lett. 2018 Mar;195:76-82. doi: 10.1016/j.imlet.2018.01.002. Epub 2018 Jan 5. Review.

PMID:
29307688
44.

Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.

Saigusa R, Asano Y, Yamashita T, Takahashi T, Nakamura K, Miura S, Ichimura Y, Toyama T, Taniguchi T, Sumida H, Tamaki Z, Miyazaki M, Yoshizaki A, Sato S.

J Dermatol Sci. 2018 Mar;89(3):282-289. doi: 10.1016/j.jdermsci.2017.12.005. Epub 2017 Dec 16.

PMID:
29279288
45.

Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide.

Numajiri H, Yoshizaki A, Ebata S, Fukasawa T, Yamashita T, Takahashi T, Taniguchi T, Asano Y, Sato S.

J Dermatol. 2018 Jun;45(6):e140-e141. doi: 10.1111/1346-8138.14189. Epub 2017 Dec 19. No abstract available.

PMID:
29265579
46.

Swimming Training Improves Myocardial Mechanics, Prevents Fibrosis, and Alters Expression of Ca2+ Handling Proteins in Older Rats.

Yoshizaki A, Antonio EL, Silva Junior JA, Crajoinas RO, Silva FA, Girardi ACC, Bocalini DS, Portes LA, Dos Santos LFN, Carlos FP, Camillo de Carvalho PT, Tucci PJF, Serra AJ.

J Gerontol A Biol Sci Med Sci. 2018 Mar 14;73(4):468-474. doi: 10.1093/gerona/glx244.

PMID:
29253100
47.

Interleukin-25 is involved in cutaneous T-cell lymphoma progression by establishing a T helper 2-dominant microenvironment.

Nakajima R, Miyagaki T, Hirakawa M, Oka T, Takahashi N, Suga H, Yoshizaki A, Fujita H, Asano Y, Sugaya M, Sato S.

Br J Dermatol. 2018 Jun;178(6):1373-1382. doi: 10.1111/bjd.16237. Epub 2018 Mar 23.

PMID:
29238954
48.

Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.

Hirabayashi M, Asano Y, Yamashita T, Miura S, Nakamura K, Taniguchi T, Saigusa R, Takahashi T, Ichimura Y, Miyagawa T, Yoshizaki A, Miyagaki T, Sugaya M, Sato S.

J Dermatol. 2018 Feb;45(2):182-188. doi: 10.1111/1346-8138.14088. Epub 2017 Oct 17.

PMID:
29044628
49.

A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.

Taniguchi T, Miyagawa T, Tamaki Z, Nakamura K, Yamashita T, Saigusa R, Takahashi T, Toyama T, Ichimura Y, Yoshizaki A, Tada Y, Sugaya M, Kadono T, Sato S, Asano Y.

Arch Dermatol Res. 2017 Dec;309(10):833-842. doi: 10.1007/s00403-017-1786-4. Epub 2017 Oct 16.

PMID:
29038846
50.

Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome.

Sakamoto M, Miyagaki T, Kamijo H, Oka T, Takahashi N, Suga H, Yoshizaki A, Asano Y, Sugaya M, Sato S.

J Dermatol. 2018 Jan;45(1):95-99. doi: 10.1111/1346-8138.14033. Epub 2017 Sep 19.

PMID:
28925057

Supplemental Content

Loading ...
Support Center